Trial Profile
First-in-human study in Hypercholesterolemia
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 07 Sep 2018
Price :
$35
*
At a glance
- Drugs NYX 330 (Primary)
- Indications Hypercholesterolaemia
- Focus Adverse reactions; First in man
- 07 Sep 2018 New trial record
- 27 Aug 2018 According to Nyrada media release, study expected to take place in 2020.